Medication management in dialysis: Barriers and strategies.
Katie E CardoneWendy M ParkerPublished in: Seminars in dialysis (2020)
People with end-stage kidney disease (ESKD) who require chronic dialysis are often reliant on complicated medication regimens to manage their health conditions. Due to the complexities of the advanced kidney disease, underlying comorbidities, and special instructions, medication regimens for patients on dialysis put patients at high risk for medication therapy problems related to safety, effectiveness, appropriateness, and adherence. This article explores the factors that affect optimal medication use for people on dialysis, including the broader drug use system, and offers recommendations around medication reconciliation, medication review, deprescribing, and considering social determinants of health to improve medication management among patients with ESKD.
Keyphrases
- end stage renal disease
- chronic kidney disease
- healthcare
- peritoneal dialysis
- adverse drug
- mental health
- newly diagnosed
- public health
- randomized controlled trial
- stem cells
- mesenchymal stem cells
- risk assessment
- metabolic syndrome
- type diabetes
- adipose tissue
- patient reported outcomes
- clinical practice
- smoking cessation
- health promotion